CARDIOPULMONARY FITNESS
ABSTRACTS 6 – 14
10. Identification of Educational Learning Needs of Cardiac Rehabilitation Patients and Health Providers GLM Ghisi1,2, SL Grace2,3, S Thomas1, M Evans4, P Oh1,2 1 University of Toronto, Faculty of Kinesiology and Physical Education, Exercise Sciences Graduate Department; 2 Toronto Rehabilitation Institute, Cardiac Rehabilitation and Prevention Program; 3 York University, School of Kinesiology and Health Science; 4 St Michael’s Hospital, Health Design Lab
Objective: to identify educational learning needs of cardiac rehabilitation (CR) patients and health providers. Methods: Two CR samples consisting of 306 patients and 28 health providers completed the Educational Needs Assessment Questionnaire (ENCR). Participants were also asked to inform their preferences for educational delivery formats. Pearson’s chi-square, t-tests and ANOVAs were used for data analysis, when applicable. Mann-Whitney U tests were used to compare needs between samples. Results: The mean total CRBS for the whole sample was 4.38±0.44. Health providers respondents reported significantly greater needs than patients overall. For 34 of 60 items, health providers’ respondents reported significantly greater barriers than their patients. However, both patients and health providers generally reported items as “important” to learn. The areas that presented the highest scores were medication, emergency/safety, and diagnosis and treatment for patients, and stress/psychological factors, emergency/safety, and risk factors for health providers. Books, lectures and discussion during consultation were identified as the preferred choices of learning by both groups. Conclusion: The findings from this study support previously studies suggesting that health providers have higher and different educational needs compared to patients. Therefore, CR patients seem to be aware of the importance of educational items presented at the ENCR. 11. The relationship between very long chain plasma ceramides and anxiety in coronary artery disease. R Rovinski1,2, M Saleem1,2, WL Swardfager1,3, PI Oh1,3, N Herrmann1,2, KL Lanctot1,2,3 1 Sunnybrook Research Institute, Neuropsychopharmacology Research Group; 2 University of Toronto; 3 Toronto Rehabilitation Institute
Purpose: Anxiety is highly prevalent in coronary artery disease (CAD), is associated with cardiovascular risk factors, and predicts poorer outcomes. Very long chain ceramides have been implicated in the development of cardiovascular disease and neurodegenerative processes previously linked to mood and anxiety disorders. This study assesses very long chain plasma ceramide concentrations as correlates of anxiety in patients with CAD. Methods: Patients with CAD were interviewed prior to beginning cardiac rehabilitation. Trait anxiety was assessed using the Spielberger State-Trait Anxiety Inventory (STAI). Depression was assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). Plasma ceramide concentrations were measured by ESI-MS/MS. Linear regression analyses were conducted to investigate cross-sectional relationships between C22:0 and C24:0 ceramide concentrations and trait anxiety. Results: In CAD (n=30, mean age=62±9 years, 86.6% male), C22:0 and C24:0 concentrations showed non significant trends with trait anxiety (β = 0.316, p=0.092; β = 0.340, p=0.068) controlling for gender and BMI. Controlling for depression still yielded trends between ceramide concentrations and trait anxiety [C22:0 (β = 0.165, p=0.165); C24:0 (β = 0.177, p=0.163)]. Conclusions: Higher plasma C22:0 and C24:0 ceramide may be associated with more severe trait anxiety. A larger sample is necessary for further investigation.
16